The firm has received approval for its HCV product, but Bristol-Myers, JNJ, Merck and others got the OK earlier.
The firm has received approval for its HCV product, but Bristol-Myers, JNJ, Merck and others got the OK earlier.
Share this Article
Comment on this Article
Recommended
Please to comment